Home > Insider Trading > Filing (0000899243-21-023629)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1580063	Progenity Inc.	PROG	()	4

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1394967	Jeffrey Ferrell	505 Fifth Avenue, Floor 18 New York NY 10017	Yes	No	Yes	No
1469000	Nb Alternatives Advisers Llc	325 N. Saint Paul Street, Suite 4900 Dallas TX 75201	No	No	Yes	No
1728001	Athyrium Capital Management, Lp	505 Fifth Avenue, Floor 18 New York NY 10017	No	No	Yes	No
1815216	Athyrium Capital Holdings, Llc	505 Fifth Avenue, Floor 18 New York NY 10017	No	No	Yes	No
1815225	Athyrium Funds Gp Holdings Llc	505 Fifth Avenue, Floor 18 New York NY 10017	No	No	Yes	No
1815407	Nb Alternatives Gp Holdings Llc	325 N. Saint Paul Street, Suite 4900 Dallas TX 75201	No	No	Yes	No
1815484	Athyrium Opportunities Advisers Llc	1290 Avenue Of The Americas, 42Nd Floor New York NY 10104	No	No	Yes	No
1815501	Nb Alternatives Holdings Llc	1290 Avenue Of The Americas, 42Nd Floor New York NY 10104	No	No	Yes	No
1835266	Athyrium Opportunities Iii Acquisition Lp	505 Fifth Avenue, Floor 18 New York NY 10017	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-06-14	8,097,166	$2.47	36,396,907	No	4	P	Indirect	See footnotes

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See footnotes

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrant	Acquisiton	2021-06-14	8,097,166	$2.47	8,097,166	$2.84

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
8,097,166	2021-06-14	2026-06-14	No	4	P	Indirect

Footnotes

The shares of the Issuer's common stock and the Warrant were purchased for $2.47 per unit, with each unit consisting of one share of the Issuer's common stock and the right to buy an additional share of the Issuer's common stock for the exercise price specified in the Warrant.
The 8,097,166 shares of the Issuer's common stock and the Warrant are directly owned by Athyrium Opportunities III Acquisition 2 LP. Athyrium Opportunities Associates III GP LLC is the general partner of Athyrium Opportunities Associates III LP, which is the general partner of Athyrium Opportunities III Acquisition 2 LP. Athyrium Funds GP Holdings, LLC is the managing member of Athyrium Opportunities Associates III GP LLC. Jeffrey Ferrell is the managing member of Athyrium Funds GP Holdings, LLC and the President of Athyrium Opportunities Associates III GP LLC.
Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein.
The Warrant represents a right to buy 8,097,166 shares of the Issuer's common stock at an exercise price of $2.84 per share. The Warrant is exercisable at any time and from time to time prior to June 14, 2026.